Skip to main content
Log in

Effects of resveratrol on NO secretion stimulated by insulin and its dependence on SIRT1 in high glucose cultured endothelial cells

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

To investigate the effects of resveratrol on the secretion of NO induced by insulin in high glucose cultured primary human umbilical vein endothelial cells (HUVEC). HUVEC were treated with 1 μmol/l resveratrol for 24 h before cultured in high glucose medium for 48 h, then all cells were stimulated by 100 nmol/l insulin for 30 min. Method based on nitric acid reductase was used to analyze the NO contents in the supernatant. Cells were collected to analyze the expression of eNOS, endothelin-1, E-selectin, and SIRT1. In order to investigate the dependence of resveratrol on SIRT1, the effects of resveratrol on cells treated by SIRT1 siRNA were also examined. Compared with control cells, high glucose decreased the secretion of NO induced by insulin. Resveratrol treatment increased the expression of SIRT1 and the secretion of NO. After interfering the expression of SIRT1 using SIRT1 siRNA, the effects of resveratrol on the NO secretion induced by insulin was impaired. Resveratrol also counteracted other pro-atherosclerotic effects of high glucose, including the up-regulating roles of high glucose on the expression of endothelin-1 mRNA and E-selectin mRNA, and the down-regulating roles of high glucose on the expression of eNOS mRNA and the basal NO secretion without the stimulating of insulin. Resveratrol can improve the NO stimulating function of insulin in high glucose cultured HUVEC in SIRT1-dependent manner. Thus, our results imply that resveratrol may have the preventive roles of atherosclerosis in diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. P.T. James, N. Rigby, R. Leach, The obesity epidemic, metabolic syndrome and future prevention strategies. Eur. J. Cardiovasc. Prev. Rehabil. 11, 3–8 (2004)

    Article  PubMed  Google Scholar 

  2. R. Ross, Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999)

    Article  CAS  PubMed  Google Scholar 

  3. A.J. Hanley, K. Williams, M.P. Stern, S.M. Haffner, Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25, 1177–1184 (2002)

    Article  PubMed  Google Scholar 

  4. J.A. Kim, M. Montagnani, K.K. Koh, M.J. Quon, Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888–1904 (2006)

    Article  PubMed  Google Scholar 

  5. R. Muniyappa, M. Montagnani, K.K. Koh et al., Cardiovascular actions of insulin. Endocr. Rev. 28, 463–491 (2007)

    Article  CAS  PubMed  Google Scholar 

  6. M. Gronbaek, A. Deis, T.I. Sorensen, U. Becker, P. Schnohr, G. Jensen, Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 310, 1165–1169 (1995)

    CAS  PubMed  Google Scholar 

  7. M. Bohm, S. Rosenkranz, U. Laufs, Alcohol and red wine: impact on cardiovascular risk. Nephrol. Dial. Transplant. 19, 11–16 (2004)

    Article  PubMed  Google Scholar 

  8. S. Renaud, M. de Lorgeril, Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523–1526 (1992)

    Article  CAS  PubMed  Google Scholar 

  9. B. Fuhrman, A. Lavy, M. Aviram, Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr. 61, 549–554 (1995)

    CAS  PubMed  Google Scholar 

  10. E.N. Frankel, A.L. Waterhouse, J.E. Kinsella, Inhibition of human LDL oxidation by resveratrol. Lancet 341, 1103–1104 (1993)

    Article  CAS  PubMed  Google Scholar 

  11. H.S. Demrow, P.R. Slane, J.D. Folts, Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 91, 1182–1188 (1995)

    CAS  PubMed  Google Scholar 

  12. F. Orsini, F. Pelizzoni, L. Verotta, T. Aburjai, C.B. Rogers, Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-beta-D-glucopyranoside and related compounds. J. Nat. Prod. 60, 1082–1087 (1997)

    Article  CAS  PubMed  Google Scholar 

  13. B. Olas, B. Wachowicz, J. Szewczuk, J. Saluk-Juszczak, W. Kaca, The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin. Microbios 105, 7–13 (2001)

    CAS  PubMed  Google Scholar 

  14. K. Iijima, M. Yoshizumi, M. Hashimoto, S. Kim, M. Eto, J. Ako, Y.Q. Liang, N. Sudoh, K. Hosoda, K. Nakahara et al., Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene. Circulation 101, 805–811 (2000)

    CAS  PubMed  Google Scholar 

  15. K. Iijima, M. Yoshizumi, M. Hashimoto, M. Akishita, K. Kozaki, J. Ako, T. Watanabe, Y. Ohike, B. Son, J. Yu, K. Nakahara, Y. Ouchi, Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways. Circulation 105, 2404–2410 (2002)

    Article  CAS  PubMed  Google Scholar 

  16. D.F. Fitzpatrick, S.L. Hirschfield, R.G. Coffey, Endothelium-dependent vasorelaxing activity of wine and other grape products. Am. J. Physiol. Heart Circ. Physiol. 265, H774–H778 (1993)

    CAS  Google Scholar 

  17. J. Lekakis, L.S. Rallidis, I. Andreadou, G. Vamvakou, G. Kazantzoglou, P. Magiatis, A.L. Skaltsounis, D.T. Kremastinos, Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur. J. Cardiovasc. Prev. Rehabil. 12, 596–600 (2005)

    Article  PubMed  Google Scholar 

  18. M. Ndiaye, M. Chataigneau, I. Lobysheva, T. Chataigneau, V.B. Schini-Kerth, Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J. 19, 455–457 (2005)

    CAS  PubMed  Google Scholar 

  19. P. Cohen, The twentieth century struggle to decipher insulin signaling. Nat. Rev. Mol. Cell Biol. 7, 867–873 (2006)

    Article  CAS  PubMed  Google Scholar 

  20. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Methta, R.C. Moon, J.M. Pezzuto, Cancer chemoprotective activity of resveratrol, a natural product derived from grapes. Science 275, 218–220 (1997)

    Article  CAS  PubMed  Google Scholar 

  21. D.S. Jang, B.S. Kang, S.Y. Ryu, I.M. Chang, K.R. Min, Y. Kim, Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem. Pharmacol. 57, 705–712 (1999)

    Article  CAS  PubMed  Google Scholar 

  22. M.I. Chung, C.M. Teng, K.L. Cheng, F.N. Ko, C.N. Lin, An antiplatelet principle of veratrum formosarum. Planta Med. 58, 274–276 (1992)

    Article  CAS  PubMed  Google Scholar 

  23. E.H. Siemann, L.L. Creasy, Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 43, 49–52 (1992)

    CAS  Google Scholar 

  24. S. Hui-Chen, H. Li-Man, C. Jan-Kan, Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290, E1339–E1346 (2006)

    Article  Google Scholar 

  25. C. Sun, F. Zhang, X. Ge et al., SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 6, 307 (2007)

    Article  CAS  PubMed  Google Scholar 

  26. Rutanen J, Yaluri N, Modi S et al., SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes (2010) [Epub ahead of print]

  27. E.N. Frankel, J. Kanner, J.B. German et al., Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet 341, 454–457 (1993)

    Article  CAS  PubMed  Google Scholar 

  28. Q. Xu, X. Hao, Q. Yang et al., Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. Biochem. Biophys. Res. Commun. 388, 389–394 (2009)

    Article  CAS  PubMed  Google Scholar 

  29. F.L. Marasciulo, M. Montagnani, M.A. Potenza, Endothelin-1: the yin and yang on vascular function. Curr. Med. Chem. 13, 1655–1665 (2006)

    Article  CAS  PubMed  Google Scholar 

  30. A. Hambrock, C.B. de Oliveira Franz, S. Hiller et al., Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner. J. Biol. Chem. 282, 3347–3356 (2007)

    Article  CAS  PubMed  Google Scholar 

  31. F. Picard, M. Kurtev, N. Chung et al., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771–776 (2004)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ping Feng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, J., Wang, N., Li, J. et al. Effects of resveratrol on NO secretion stimulated by insulin and its dependence on SIRT1 in high glucose cultured endothelial cells. Endocr 37, 365–372 (2010). https://doi.org/10.1007/s12020-010-9314-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-010-9314-8

Keywords

Navigation